Mitt Romney was 'treated successfully' for prostate cancer

Former Republican U.S. presidential nominee Mitt Romney speaks critically about then-Republican presidential candidate Donald Trump and the state of the 2016 Republican presidential campaign during a speech at the Hinckley Institute of Politics at the University of Utah in Salt Lake City, Utah March 3, 2015. (Jim Urquhart/Reuters)
Former Republican U.S. presidential nominee Mitt Romney speaks critically about then-Republican presidential candidate Donald Trump and the state of the 2016 Republican presidential campaign during a speech at the Hinckley Institute of Politics at the University of Utah in Salt Lake City, Utah March 3, 2015. (Jim Urquhart/Reuters)

Mitt Romney, the 2012 Republican presidential nominee who is preparing for a possible Senate campaign in Utah, was treated for prostate cancer last summer, a person close to Romney said Monday.

Romney’s prognosis was described as “very good” and he was “treated successfully,” according to this person, who requested anonymity because of the sensitivity of the matter.

“Mitt Romney was treated over the summer for prostate cancer,” this person said. “He was treated surgically by Dr. Thomas Ahlering at UC Irvine Hospital in California. His prognosis is very good. He was treated successfully.”

Romney, 70, is in good heath and went skiing with family in recent days, this person said. Though he has not announced his future political plans, Romney is widely expected to mount a run later for the Senate seat being vacated at the end of this year by the retiring Sen. Orrin Hatch, R-Utah.

During his 2012 presidential campaign, Romney released a letter about his health from his longtime personal physician, Dr. Randall Gaz at Massachusetts General Hospital, who described the then-candidate as a “healthy appearing, energetic, strong, physically fit male.”

Gaz wrote that Romney had a mild enlargement of the prostate and that his family has a history of prostate cancer.

CONTINUE READING

MORE Nation & World ARTICLES TO READ NEXT ...

This month the financial website 24/7 Wall St. published its list of America's 20 Most Hated Companies, based on consumer surveys and other metrics.The list bears watching. It provides a rogues' gallery of how companies get in tro ...

Drug regulators want to let drugmakers test Alzheimer's disease treatments on patients years before the disease shows outward signs, and could approve the therapies based on subtle biological signals rather than proof they allevia ...

Give us feedback

Have you found an error or omission in our reporting? Tell us here.

Do you have a story idea we should look into? Tell us here.